Page 367 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 367

CARDIOvASCuLAR  ``CARdIOvASCulAR—PHARMACOlOGY  CARDIOvASCuLAR  ``CARdIOvASCulAR—PHARMACOlOGY          SECTION III      323




                  Antiarrhythmics—       Metoprolol, propranolol, esmolol, atenolol, timolol, carvedilol.
                  β-blockers (class II)
                                                                                    2+
                   MECHANISM             Decrease SA and AV nodal activity by  cAMP,  Ca  currents. Suppress abnormal pacemakers by
                                           slope of phase 4.
                                         AV node particularly sensitive— PR interval. Esmolol very short acting.
                   ClINICAl uSE          SVT, ventricular rate control for atrial fibrillation and atrial flutter.
                   AdvERSE EFFECTS       Impotence, exacerbation of COPD and asthma, cardiovascular effects (bradycardia, AV block, HF),
                                          CNS effects (sedation, sleep alterations). May mask the signs of hypoglycemia.
                                         Metoprolol can cause dyslipidemia. Propranolol can exacerbate vasospasm in vasospastic angina.
                                          β-blockers (except the nonselective α- and β-antagonists carvedilol and labetalol) cause unopposed
                                          α 1 -agonism if given alone for pheochromocytoma or for cocaine toxicity (unsubstantiated). Treat
                                          β-blocker overdose with saline, atropine, glucagon.
                                                               60  Decrease slope        Prolonged
                                                                                         repolarization
                                                                   of phase 4
                                                              Membrane potential (mv)  –30 0     Threshold
                                                                   depolarization
                                                                                         (at AV node)
                                                                30
                                                                                                 potential
                                                               –60
                                                               –90
                                                                 0   100  200  300  400  500  600  700  800
                                                                                 Time (ms)
                                                                          Pacemaker cell action potential


                  Antiarrhythmics—       Amiodarone, Ibutilide, Dofetilide, Sotalol.  AIDS.
                  potassium channel
                  blockers (class III)
                   MECHANISM              AP duration,  ERP,  QT interval.
                   ClINICAl uSE          Atrial fibrillation, atrial flutter; ventricular
                                          tachycardia (amiodarone, sotalol).

                   AdvERSE EFFECTS       Sotalol—torsades de pointes, excessive β   Remember to check PFTs, LFTs, and TFTs when
                                          blockade.                                using amiodarone.
                                         Ibutilide—torsades de pointes.           Amiodarone is lipophilic and has class I, II, III,
                                         Amiodarone—pulmonary fibrosis,            and IV effects.
                                          hepatotoxicity, hypothyroidism or
                                          hyperthyroidism (amiodarone is 40% iodine by
                                          weight), acts as hapten (corneal deposits, blue/
                                          gray skin deposits resulting in photodermatitis),
                                          neurologic effects, constipation, cardiovascular
                                          effects (bradycardia, heart block, HF).

                                                             0 mV
                                                                                          Markedly prolonged
                                                                                          repolarization (I )
                                                                                                   K


                                                            −85 mV
                                                                              Cell action potential












          FAS1_2019_07-Cardio.indd   323                                                                                11/7/19   4:24 PM
   362   363   364   365   366   367   368   369   370   371   372